Treatment of DCs with PSA-containing MVs prevented trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice via suppression of the proinflammatory cytokines, TNF-α and IL-17, and increased secretion of IL-10. Here, TNF is linked to colitis.